Clinical Trial Update: A Clinical Study to Evaluate Safety, Tolerance, Pharmacokinetics and Efficacy of Sc610 Injection for Treating Advanced Urinary System Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating safety, tolerance, pharmacokinetics, and efficacy of Sc610 injection for advanced urinary system tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Tumor of the Urinary System

Drugs mentioned

• Sc610 injection

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Malignant Tumor of Urinary System (Disorder) | Phase 1, Phase 2 | Status: UNKNOWN